Similar articles

• Sigma receptors and sigma ligands: background to a pharmacological enigma.

  Leonard BE. Leonard BE. Pharmacopsychiatry. 2004 Nov;37 Suppl 3:S166-70. doi: 10.1055/s-2004-832674. Pharmacopsychiatry. 2004. PMID: 15547782 Review.
• [Functional characterization of a sigma receptor and its gene expression by haloperidol].

  Nakata Y, Inoue A, Sugita S. Nakata Y, et al. Nihon Yakurigaku Zasshi. 1999 Jul;114(1):61-8. doi: 10.1254/fpj.114.61. Nihon Yakurigaku Zasshi. 1999. PMID: 10562966 Review. Japanese.
• Novel piperidine sigma receptor ligands as potential antipsychotic drugs.

  Gilligan PJ, Cain GA, Christos TE, Cook L, Drummond S, Johnson AL, Kergaye AA, McElroy JF, Rohrbach KW, Schmidt WK, et al. Gilligan PJ, et al. J Med Chem. 1992 Nov 13;35(23):4344-61. doi: 10.1021/jm00101a012. J Med Chem. 1992. PMID: 1360026
• DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles.

  Tam SW, Steinfels GF, Gilligan PJ, Schmidt WK, Cook L. Tam SW, et al. J Pharmacol Exp Ther. 1992 Dec;263(3):1167-74. J Pharmacol Exp Ther. 1992. PMID: 1361572
• Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.

  Inoue A, Sugita S, Shoji H, Ichimoto H, Hide I, Nakata Y. Inoue A, et al. Eur J Pharmacol. 2000 Aug 11;401(3):307-16. doi: 10.1016/s0014-2999(00)00455-6. Eur J Pharmacol. 2000. PMID: 10936488